Evidence map›Paper›PMID 25909835›Full record

SynthesisBlood cancer journal2015

Haematological cancer and quality of life: a systematic literature review.

P Allart-Vorelli, B Porro, F Baguet, A Michel, F Cousson-Gélie

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in Blood cancer journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04236063 (Rehabilitation Needs of the Malaysian Haematological Cancer Survivors Through a Single Centre Experience), which is not on this map. Cited by 73 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04236063 completednot on this mapstarted 2019, after this paper: background citation

Rehabilitation Needs of the Malaysian Haematological Cancer Survivors Through a Single Centre Experience

Typeobservational_patient_registrySponsorUniversity of MalayaRan2019 to 2020Enrolled168ConditionsHaematological Malignancy, Leukemia, Acute, Lymphoma, Myeloma MultipleArmsWHODAS 2.0 Questionnaire
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Electronic patient-reported outcome platforms used in hematological cancers: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Effects of nurse-led symptom management in chronic myeloid malignancies: a randomized trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial
  7. Caregivers' proxy assessments of health-related quality of life in patients with hematologic malignancies.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  8. Cancer pain.Nature reviews. Disease primers · 2026
    Review
  9. Review
  10. Article
  11. Circulating Tumor Cells: Emerging Frontiers in Cancer Technology.Expert reviews in molecular medicine · 2026
    Review
  12. Article
  13. Article
  14. Sexual health in older adults with hematologic malignancies - a sub-analysis of a Danish cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

P Allart-VorelliLaboratory of Psychology 'Health and Quality of Life' EA 4139, University Bordeaux Segalen, Bordeaux, France.
B PorroDepartment of Psychology, Epsylon EA 4556 Laboratory 'Dynamics of Human Abilities and Health Behaviors', University Paul Valéry Montpellier 3, Montpellier, France.
F Baguet1] Department of Psychology, Epsylon EA 4556 Laboratory 'Dynamics of Human Abilities and Health Behaviors', University Paul Valéry Montpellier 3, Montpellier, France [2] ICM, Institut Régional du Cancer de Montpellier, Epidaure Prevention Unit - Rue des Apothicaires, Montpellier Cedex 5, France.
A Michel1] Department of Psychology, Epsylon EA 4556 Laboratory 'Dynamics of Human Abilities and Health Behaviors', University Paul Valéry Montpellier 3, Montpellier, France [2] MIS, Montpellier Institut du Sein - 25 rue de Clémentville, Montpellier, France.
F Cousson-Gélie1] Department of Psychology, Epsylon EA 4556 Laboratory 'Dynamics of Human Abilities and Health Behaviors', University Paul Valéry Montpellier 3, Montpellier, France [2] ICM, Institut Régional du Cancer de Montpellier, Epidaure Prevention Unit - Rue des Apothicaires, Montpellier Cedex 5, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to examine the impact of haematological cancers on quality of life (QoL). A review of the international literature was conducted from the databases 'PsycInfo' and 'Medline' using the keywords: 'haematological cancer', 'quality of life', 'physical', 'psychological', 'social', 'vocational', 'professional', 'economic', 'cognitive', and 'sexual'. Twenty-one reliable studies were analysed. Among these studies, 12 showed that haematological cancer altered overall QoL, 8 papers found a deterioration of physical dimension, 8 papers reported on functional and role dimensions, 11 papers reported on the psychological component and 9 on the social component. Moreover, one study and two manuscripts, respectively, reported deteriorated sexual and cognitive dimensions. Our review demonstrates that the different dimensions of QoL are deteriorated by haematological malignancies and, probably, by the side effects of treatment.

Indexed as

Quality of LifeHematologic NeoplasmsHumans

Identifiers

PMID25909835
PMCPMC4450328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.